CytoStorm develops the Inflex System, an extracorporeal blood-purification device designed to rapidly remove drugs, toxins, and inflammatory mediators in emergency settings. The system is intended to treat critical conditions including opioid overdoses and liver coma.
Get notified the moment CytoStorm, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.